HCP Live March 7, 2024
Connor Iapoce

Continuous glucose monitoring was associated with lower odds of diabetic retinopathy development, even after adjusting for hemoglobin A1c levels.

Continuous glucose monitoring (CGM), an integral tool in diabetes care, was associated with a reduced likelihood of developing diabetic retinopathy and proliferative diabetic retinopathy (PDR) in adults with type 1 diabetes (T1D).1

The retrospective cohort study involved a diverse population of adults with T1D who had consultations at an academic tertiary diabetes center and ophthalmology center between 2013 and 2021. The positive association with CGM use remained after adjustment for hemoglobin A1c (HbA1c) levels in this adult population.

“As the use of CGM in the management of T1D continues to increase, it may help mitigate the development of DR and vision...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices, Survey / Study, Trends
Boston Scientific to acquire SoniVie for $540 million, expand hypertension treatment portfolio
Medicare Coverage Of Medical Technologies In A New Era
This year's top congressional medical technology priorities
Boston Scientific to acquire devicemaker: 3 things to know
Everything You Need To Know Before Getting An RFID Implant - 3

Share This Article